News
Announcements, press releases, and conference appearances from CareCentra.
12 stories
AI technology a game changer for treatment of COPD and asthma
KSL reports on the two-year Intermountain Health and CareCentra study, finding that continuous, AI-driven monitoring between clinic visits reduced total cost of care by 57%, hospitalizations by 50%, and emergency department visits by 20% for patients with COPD and asthma.
Read on KSLThe Future of Respiratory Care: AI-Powered Monitoring Becomes Standard of Care
See how an AI-powered app co-created in Utah enables around-the-clock monitoring and predictive analysis for chronic lung disease patients — cutting direct costs by 57% and observation bed use by 73%, and expanding to become the standard of care across the Intermountain Health system.
Watch VideoLiving with COPD: How iCARE Gave Patients Their Lives Back
Patients and clinicians share firsthand testimonials on how the iCARE remote monitoring program transformed life with chronic lung disease — replacing fear and isolation with confidence, connection, and a direct line to their care team.
Watch VideoNew Intermountain Health Study Finds AI Technology is a 'Game Changer' in the Treatment of Pulmonary Patients with COPD and Asthma
ABC4 Utah's Good Things Utah covers how Intermountain Health researchers conducted a landmark study showing AI technology can streamline and enhance care for COPD and asthma patients, calling the results a 'game changer' for millions living with chronic pulmonary conditions.
Read on ABC4 UtahAI-powered home monitoring cuts hospitalizations for lung disease patients
Channel 4 Utah reports on Intermountain Health's study showing AI-driven at-home monitoring reduced hospitalizations by 50%, ER visits by 20%, and healthcare costs by 60% for patients with chronic lung conditions.
Watch VideoInnovative AI assistant slashes lung condition hospitalizations by 50%
KSL TV reports on Intermountain Health's landmark study showing AI combined with remote monitoring cut hospitalizations by 50% and ER visits by 20% for COPD and asthma patients, with a patient testimonial on how the technology has transformed their daily care.
Watch VideoInnovative AI assistant brings a brighter future to patients with chronic pulmonary conditions
KSL reports on how CareCentra's AI-powered platform is giving COPD and asthma patients a new tool for managing their conditions between clinic visits, reducing hospitalizations and improving quality of life.
Read on KSLIntermountain Health app uses artificial intelligence to treat COPD, asthma
Deseret News covers how Intermountain Health and CareCentra's iCARE program is using continuous AI monitoring and digital twins to prevent respiratory exacerbations before they happen.
Read on Deseret NewsAI technology could be a game-changer for treating chronic pulmonary conditions
AOL News covers the Intermountain Health and CareCentra iCARE study results, reporting how AI-driven continuous monitoring is transforming outcomes for patients with COPD and asthma.
Read on AOL NewsAI technology could be a game-changer for treating COPD and asthma
Yahoo News highlights findings from the Intermountain Health and CareCentra iCARE study, reporting that AI-powered continuous monitoring is reshaping how clinicians manage two of the most common chronic pulmonary conditions worldwide.
Read on Yahoo NewsNew Intermountain study finds AI technology is a game-changer for the treatment of two of the most common chronic pulmonary conditions in the world
Intermountain Health announces results from the iCARE study showing that AI-powered continuous monitoring transformed care for COPD and asthma patients, cutting hospitalizations and total cost of care while expanding navigator capacity.
Read on Intermountain Health NewsroomClosing the Gap Between Clinic Visits: What 1,200 Patients Taught Us About Continuous Respiratory Care
Results from iCARE, a two-year study with Intermountain Health and CareCentra: continuous AI monitoring of 1,200 COPD and asthma patients cut total cost of care by 57% and hospital admissions by 50%.
Read Full Release